Table 2.
Results of main laboratory test.
| Index (normal range) | Nov. 8th | 10th | 12th | 14th | 16th | 20th | 23th | 27th | 29th | 30th |
|---|---|---|---|---|---|---|---|---|---|---|
| REGULAR BLOOD ANALYSIS | ||||||||||
| White blood cell count (3.97~9.15 × 10∧9/L) | 8.53 | – | – | – | – | – | – | – | 15.65 | 24.86 |
| Neutrophils% (50~70%) | 54.8 | – | – | – | – | – | – | – | 85.0 | 89.9 |
| Platelet count (85~303 × 10∧9/L) | 200 | – | – | – | – | – | – | – | 133 | 121 |
| Red blood cell count (4.09~5.74 × 10∧12/L) | 5.56 | – | – | – | – | – | – | – | 3.85 | 3.61 |
| Triglyceride (<1.7 mmol/L) | 2.75 | – | – | – | – | – | – | – | – | – |
| Total cholesterol (<5.72 mmol/L) | 3.38 | – | – | – | – | – | – | – | – | – |
| Total bilirubin (3.4~17.1 umol/L) | 13.5 | – | – | – | – | – | – | – | 36.0 | – |
| High density lipoprotein (0.9~2.0 mmol/L) | 0.61 | – | – | – | – | – | – | – | – | – |
| Low density lipoprotein (0.9~2.0 mmol/L) | 1.70 | – | – | – | – | – | – | – | – | – |
| Non high density lipoprotein (1.8~4.1 mmol/L) | 2.77 | – | – | – | – | – | – | – | – | – |
| Creatinine (45~104 umol/L) | 115.0 | – | 119.0 | – | 144.0 | 144.0 | 150.0 | – | 138.0 | 157.0 |
| Blood ketone body (negative) | Negative | – | – | – | – | – | – | – | – | – |
| Blood ammonia (9~30 umol/L) | 72.48 | – | – | – | – | – | – | – | – | – |
| Erythrocyte sedimentation rate (0.0~15.0 mm/h) | 29 | – | – | – | – | – | – | – | – | – |
| Glycosylated hemoglobin Hba1C (4~6%) | 7.0 | – | – | – | – | – | – | – | – | – |
| 2 h blood glucose (<7.8 mmol/l) | 8.32 | – | – | – | – | – | – | – | – | – |
| High sensitive C reactive protein (0~3 mg/L) | 2.9 | – | – | – | – | – | – | – | – | – |
| B type natriuretic peptide (0.0~100 pg/mL) | 188.00 | 160.0 | – | – | – | – | – | – | – | – |
| MYOCARDIAL INFARCTION MARKERS | ||||||||||
| Troponin (<0.04 ng/mL) | 0.01 | – | – | – | – | – | – | – | 10.65 | 4.01 |
| Creatine kinase (0.6~6.3 ng/mL) | 0.7 | – | – | – | – | – | – | – | 639 | – |
| Myoglobin (17.4~105.7 ng/mL) | 33.10 | – | – | – | – | – | – | – | – | – |
| BLOOD COAGULATION ANALYSIS | ||||||||||
| Fibrin degradation product (0~5 μg/ml) | 5.90 | 10.10 | – | – | – | – | – | – | – | – |
| Thrombin time (14~21 s) | 20.50 | 20.70 | – | – | – | – | – | – | – | – |
| Prothrombin time (9.4~12.5 s) | 12.00 | 14.70 | – | 13.5 | 18.50 | 36.00 | 37.30 | 11.4 | – | – |
| Fibrinogen (2.00~4.00 g/L) | 3.75 | 3.67 | – | – | – | – | – | – | – | – |
| Activated partial prothrombin time (25~33.8 s) | 28.20 | 30.10 | – | – | – | – | – | – | – | – |
| Prothrombin INR (0.8~1.15) | 1.01 | 1.23 | – | 1.13 | 1.65 | 2.99 | 3.10 | 1.03 | – | – |
| D–Dimer (0~0.5 μg/mL) | 0.95 | 1.48 | – | – | – | – | – | – | – | – |
| ECHOCARDIOGRAPHY | ||||||||||
| Internal diameter of the aortic root (28~40 mm) | 37 | – | – | – | – | – | – | – | – | – |
| Left atrial diameter (30~40 mm) | 46 | – | – | – | – | – | – | – | – | – |
| The left ventricular ejection fraction (55%) | 52 | – | – | – | – | – | – | – | – | – |
| Left ventricular end diastolic diameter (38~52 mm) | 48 | – | – | – | – | – | – | – | – | – |
Data were collected from Nov. 8th 2017 to Nov. 30th 2017. Nov., November; -, No tested.